ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 3 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,255,320 | +61.7% | 69,200 | +73.4% | 0.04% | +70.8% |
| Q2 2023 | $7,578,606 | -8.4% | 39,900 | -3.4% | 0.02% | -20.0% |
| Q1 2023 | $8,273,216 | -18.3% | 41,300 | -3.1% | 0.03% | +25.0% |
| Q4 2022 | $10,123,890 | +68.6% | 42,600 | +42.0% | 0.02% | +100.0% |
| Q3 2022 | $6,005,000 | -54.0% | 30,000 | -66.5% | 0.01% | -40.0% |
| Q2 2022 | $13,068,000 | +296.2% | 89,600 | +343.6% | 0.02% | +566.7% |
| Q1 2022 | $3,298,000 | -56.1% | 20,200 | -54.4% | 0.00% | -50.0% |
| Q4 2021 | $7,512,000 | -1.5% | 44,300 | +9.7% | 0.01% | -25.0% |
| Q3 2021 | $7,628,000 | +116.3% | 40,400 | +94.2% | 0.01% | +100.0% |
| Q2 2021 | $3,526,000 | +296.2% | 20,800 | +230.2% | 0.00% | +300.0% |
| Q1 2021 | $890,000 | -84.1% | 6,300 | -85.3% | 0.00% | -90.0% |
| Q4 2020 | $5,589,000 | -14.9% | 43,000 | -4.7% | 0.01% | -52.4% |
| Q3 2020 | $6,567,000 | +103.4% | 45,100 | +106.9% | 0.02% | +40.0% |
| Q2 2020 | $3,229,000 | -50.6% | 21,800 | -63.7% | 0.02% | -71.7% |
| Q1 2020 | $6,531,000 | -27.5% | 60,000 | -23.3% | 0.05% | -13.1% |
| Q4 2019 | $9,006,000 | +13.3% | 78,200 | -20.9% | 0.06% | -4.7% |
| Q3 2019 | $7,946,000 | +434.4% | 98,800 | +382.0% | 0.06% | +392.3% |
| Q2 2019 | $1,487,000 | -60.9% | 20,500 | -49.6% | 0.01% | -69.0% |
| Q1 2019 | $3,803,000 | -51.5% | 40,700 | -62.2% | 0.04% | -38.2% |
| Q4 2018 | $7,845,000 | -19.8% | 107,600 | -3.7% | 0.07% | -11.7% |
| Q3 2018 | $9,776,000 | +26.9% | 111,700 | +42.8% | 0.08% | +16.7% |
| Q2 2018 | $7,702,000 | +282.6% | 78,200 | +362.7% | 0.07% | +230.0% |
| Q1 2018 | $2,013,000 | -37.4% | 16,900 | -33.2% | 0.02% | -13.0% |
| Q4 2017 | $3,214,000 | -80.5% | 25,300 | -81.9% | 0.02% | -84.6% |
| Q3 2017 | $16,460,000 | +358.6% | 140,100 | +211.3% | 0.15% | +302.7% |
| Q2 2017 | $3,589,000 | +104.7% | 45,000 | +31.6% | 0.04% | +85.0% |
| Q1 2017 | $1,753,000 | +23.2% | 34,200 | -10.0% | 0.02% | +42.9% |
| Q4 2016 | $1,423,000 | -70.4% | 38,000 | -46.5% | 0.01% | -73.1% |
| Q3 2016 | $4,812,000 | +73.4% | 71,000 | +42.0% | 0.05% | +57.6% |
| Q2 2016 | $2,775,000 | +6.8% | 50,000 | +20.8% | 0.03% | -10.8% |
| Q1 2016 | $2,599,000 | +120.8% | 41,400 | +231.2% | 0.04% | +164.3% |
| Q4 2015 | $1,177,000 | +49.4% | 12,500 | +27.6% | 0.01% | +27.3% |
| Q3 2015 | $788,000 | +13.4% | 9,800 | +69.0% | 0.01% | +10.0% |
| Q2 2015 | $695,000 | -66.7% | 5,800 | -71.0% | 0.01% | -69.7% |
| Q1 2015 | $2,088,000 | -25.5% | 20,000 | -30.8% | 0.03% | -21.4% |
| Q4 2014 | $2,803,000 | +80.4% | 28,900 | +45.2% | 0.04% | +75.0% |
| Q3 2014 | $1,554,000 | +134.4% | 19,900 | +89.5% | 0.02% | +140.0% |
| Q2 2014 | $663,000 | +795.9% | 10,500 | +854.5% | 0.01% | +900.0% |
| Q1 2014 | $74,000 | -69.7% | 1,100 | -71.1% | 0.00% | -75.0% |
| Q4 2013 | $244,000 | -76.2% | 3,800 | -76.2% | 0.00% | -80.0% |
| Q3 2013 | $1,024,000 | -20.4% | 16,000 | -61.4% | 0.02% | -37.5% |
| Q2 2013 | $1,287,000 | – | 41,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,500 | $1,177,000 | 0.01% |
| Timber Hill LLC | 7,700 | $725,000 | 0.00% |
| SIMPLEX TRADING, LLC | 189 | $46,000 | 0.00% |
| Citadel Advisors | 10,500 | $988,000 | 0.00% |